Cargando…

SARS-CoV-2 Variants and Vaccines

Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krause, Philip R., Fleming, Thomas R., Longini, Ira M., Peto, Richard, Briand, Sylvie, Heymann, David L., Beral, Valerie, Snape, Matthew D., Rees, Helen, Ropero, Alba-Maria, Balicer, Ran D., Cramer, Jakob P., Muñoz-Fontela, César, Gruber, Marion, Gaspar, Rogerio, Singh, Jerome A., Subbarao, Kanta, Van Kerkhove, Maria D., Swaminathan, Soumya, Ryan, Michael J., Henao-Restrepo, Ana-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262623/ https://www.ncbi.nlm.nih.gov/pubmed/34161052 http://dx.doi.org/10.1056/NEJMsr2105280

Ejemplares similares

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

Considerations in boosting COVID-19 vaccine immune responses
por: Krause, Philip R, et al.
Publicado: (2021)

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
por: Krause, Philip R, et al.
Publicado: (2022)

COVID-19 vaccine trials: The use of active controls and non-inferiority studies
por: Fleming, Thomas R, et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
por: Longini, Ira M, et al.
Publicado: (2022)

Data sharing for novel coronavirus (COVID-19)
por: Moorthy, Vasee, et al.
Publicado: (2020)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool
por: Bellan, Steven E., et al.
Publicado: (2019)

Optimizing Vaccine Allocation at Different Points in Time during an Epidemic
por: Matrajt, Laura, et al.
Publicado: (2010)

H5N1 Viruses and Vaccines
por: Subbarao, Kanta, et al.
Publicado: (2007)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

Animal Models for Sars
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

Respiratory Virus Infections: Understanding COVID-19
por: Subbarao, Kanta, et al.
Publicado: (2020)

2009 versus 2010 comparison of influenza activity in southern hemisphere temperate countries
por: Van Kerkhove, Maria D., et al.
Publicado: (2011)

Identification of MERS-CoV in dromedary camels
por: Ferguson, Neil M, et al.
Publicado: (2014)

Detecting Human-to-Human Transmission of Avian Influenza A (H5N1)
por: Yang, Yang, et al.
Publicado: (2007)

A39 Reconstruction of Ebola chains of transmission using sequence and epidemiological data
por: Robert, A, et al.
Publicado: (2019)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Vaccines for Pandemic Influenza
por: Luke, Catherine J., et al.
Publicado: (2006)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Public health response to COVID-19: Global perspective
por: Van Kerkhove, Maria
Publicado: (2021)

Association between psychological factors and temporomandibular disorders in adolescents of rural and urban zones
por: Restrepo, Claudia, et al.
Publicado: (2021)

Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread
por: Handel, Andreas, et al.
Publicado: (2007)

Preclinical and clinical developments for combination treatment of influenza
por: Koszalka, Paulina, et al.
Publicado: (2022)

Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza
por: Matrajt, Laura, et al.
Publicado: (2013)

Estimates of Serial Interval and Reproduction Number of Sudan Virus, Uganda, August–November 2022
por: Marziano, Valentina, et al.
Publicado: (2023)

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
por: Pirie, Kirstin, et al.
Publicado: (2013)

Lung cancer in never smokers in the UK Million Women Study
por: Pirie, Kirstin, et al.
Publicado: (2016)

A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination
por: Dighe, Amy, et al.
Publicado: (2019)

Respiratory Virus Vaccines
por: Broadbent, Andrew J., et al.
Publicado: (2015)

Controlling Endemic Cholera with Oral Vaccines
por: Longini, Ira M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_rkkt2kmtdudb6dnkc9k10anoac